Show Summary Details
Page of

Disorders relating to use of PCP and hallucinogens 

Disorders relating to use of PCP and hallucinogens
Disorders relating to use of PCP and hallucinogens

Henry David Abraham

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 01 July 2022

Phencyclidine (PCP, ‘angel dust’) is an arylcyclohexylamine dissociative anaesthetic. It was first abused in the United States in New York and San Francisco in the 1960s, but abuse declined when a broad range of adverse complications was noted. Agents that alter perception and mood without disorientation typify hallucinogenic drugs. They have been known and used for millennia for purposes ranging from magical to medical. Hallucinogenic drugs comprise not so much a single class of compounds, but a multiple classes affecting different neuronal receptors. This chapter looks at the epidemiology, acute physiological effects, and adverse effects of both PCP and hallucinogens. it also covers PCP delirium, PCP-induced psychotic disorder, PCP abuse, dependence, and organic mental disorder, and finally human experimentation with hallucinogens.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.